ScreenerHero

SIGA SIGA Technologies, Inc.

NAS · US · Healthcare · Drug Manufacturers - Specialty & Generic · siga.com
3.260USD-0.91%Mkt Cap: 234.23M $P/E: —

SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security market in the United States. The company's lead product is TPOXX, an antiviral drug for the treatment of human smallpox d…

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
MRK
Merck KGaA
$66.23BUSDP/E 25.7
TAK
Takeda Pharmaceutical Company Limited
$58.68BUSD
TEVA
Teva Pharmaceutical Industries Limited
$45.70BUSDP/E 65.3
GALD
Galderma Group AG
$43.27BUSDP/E 56.1
HLN
Haleon plc
$39.67BUSDP/E 18.4
SDZ
Sandoz Group AG
$34.93BUSDP/E 60.5
HLN
Haleon plc
$32.73BUSDP/E 19.0
ZTS
Zoetis Inc.
$29.57BUSDP/E 11.8
ZOE
Zoetis Inc.
$28.56BUSDP/E 12.2
UTHR
United Therapeutics Corporation
$23.38BUSDP/E 19.5
VTRS
Viatris Inc.
$20.09BUSD
SOBI
Swedish Orphan Biovitrum AB (publ)
$14.43BUSDP/E 112.9
NBIX
Neurocrine Biosciences, Inc.
$14.58BUSDP/E 21.0
IPN
Ipsen S.A.
$12.99BUSDP/E 23.5
ELAN
Elanco Animal Health Incorporated
$11.17BUSD
RDY
Dr. Reddy's Laboratories Limited
$10.22BUSDP/E 27.9
KRK
Krka, d. d.
$8.66BUSDP/E 19.3
ALKS
Alkermes plc
$6.95BUSDP/E 109.1
HIMS
Hims & Hers Health, Inc.
$6.89BUSD
AMRX
Amneal Pharmaceuticals, Inc.
$6.84BUSDP/E 40.1

Key Statistics

Company
Market Cap234.23M USD
Enterprise Value119.24M USD
Revenue (TTM)53.66M USD
Gross Profit64.87M USD
Net Income (TTM)23.28M USD
Revenue/Share0.75 USD
Last Price3.260 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees49
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)3.05
PEG3.37
EV/EBITDA-11.30
EV/Revenue2.22
P/S4.41
P/B1.43
EPS (TTM)-0.04
EPS (Forward)1.08
52W Range
2.8307% of range9.290
52W High9.290 USD
52W Low2.830 USD
Profitability
Gross Margin68.59%
Oper. Margin33.91%
EBITDA Margin-19.66%
Profit Margin24.61%
ROE11.71%
ROA10.61%
Growth
Revenue Growth-49.50%
Earnings Growth-65.30%
Cash Flow & Leverage
Operating CF43.47M USD
CapEx (TTM)355.01K USD
FCF Margin-44.70%
FCF Yield-10.24%
Net Debt-117.15M USD
Net Debt/EBITDA11.11
Balance Sheet
Debt/Equity0.00
Current Ratio21.72
Quick Ratio15.90
Book Value/Sh2.30 USD
Cash/Share1.64 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div DateApr 7, 2026
Pay DateApr 23, 2026
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.71.85M
Float41.13M
Insiders42.73%
Institutions50.11%
Short Interest
Short Ratio5.2d
Short % Float8.02%
Short % Out.5.19%
Shares Short3.73M
Short (prev mo.)3.84M
Technical
SMA 503.154 (+3.4%)
SMA 2004.674 (-30.3%)
Beta0.96
S&P 52W Chg16.45%
Avg Vol (30d)712.57K
Avg Vol (10d)748.15K
Technical Indicators
RSI (14)49.2
MACD0.0467
MACD Signal0.0404
MACD Hist.+0.0063
BB Upper3.549 USD
BB Middle3.253 USD
BB Lower2.958 USD
BB Width18.19%
ATR (14)0.1624 USD
Vol Ratio (20d)0.62x